Global Pharmaceuticals & Biotech Big Green Snowflakes

TME Pharma

Market Cap: €9.7m

A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.

Eusol BiotechLtd

Market Cap: NT$1.1b

Focuses on research and development of new biotech drugs for sleep disorders.

Carna Biosciences

Market Cap: JP¥4.2b

A clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan.

Barinthus Biotherapeutics

Market Cap: US$44.8m

A clinical-stage biopharmaceutical company, focuses on developing immunotherapeutic drug candidates for treating auto-immune and inflammatory diseases.

GlaxoSmithKlineE

Market Cap: ج.م5.5b

Engages in production of pharmaceutical chemicals.

Newbury Pharmaceuticals

Market Cap: SEK 77.8m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Aptevo Therapeutics

Market Cap: US$4.9m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

Astria Therapeutics

Market Cap: US$422.7m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

Silence Therapeutics

Market Cap: US$227.2m

A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

Malin

Market Cap: €34.4m

Through its subsidiaries, operates in the life sciences industry in Ireland and the United States.

Oxurion

Market Cap: €1.2m

A biopharmaceutical company, develops medicines to prevent blindness in Belgium.

Alnylam Pharmaceuticals

Market Cap: US$61.5b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

PCI Biotech Holding

Market Cap: NOK 15.1m

A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.

iAnthus Capital Holdings

Market Cap: CA$67.8m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Can B

Market Cap: US$1.6m

Engages in the protection and commercialization of cannabis patents.

CEL-SCI

Market Cap: US$77.4m

A clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.

Sandoz Group

Market Cap: CHF 20.8b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Crescita Therapeutics

Market Cap: CA$8.7m

A dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally.

Septerna

Market Cap: US$656.3m

A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.

Ventyx Biosciences

Market Cap: US$169.0m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

Nicox

Market Cap: €26.9m

Operates as an ophthalmology company in France and internationally.

Nanoform Finland Oyj

Market Cap: €71.5m

Engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.

Quia Pharma

Market Cap: SEK 7.3m

Engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform.

Ind-Swift

Market Cap: ₹850.4m

Develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India.

Shanghai Henlius Biotech

Market Cap: HK$43.2b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Brooks Laboratories

Market Cap: ₹4.5b

Manufactures and sells pharmaceuticals in India and internationally.

JCR Pharmaceuticals

Market Cap: JP¥77.3b

Engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan.

Argenica Therapeutics

Market Cap: AU$43.0m

A biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.

FunPep

Market Cap: JP¥4.6b

Engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides.

JW (Cayman) Therapeutics

Market Cap: HK$2.1b

A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.

Zhejiang Starry PharmaceuticalLtd

Market Cap: CN¥5.2b

Engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally.

Colinz Laboratories

Market Cap: ₹106.3m

Manufactures, markets, and trades in pharmaceutical formulations in India.

Bukwang Pharmaceutical

Market Cap: ₩343.8b

Develops, produces, and sells pharmaceutical products in South Korea and internationally.

Rua Bioscience

Market Cap: NZ$12.4m

Engages in the research, development, and manufacturing of pharmaceutical products in New Zealand and internationally.

Hamps Bio

Market Cap: ₹256.1m

Provides pharmaceutical, freeze dried, and frozen products in India and internationally.

Searle

Market Cap: PK₨61.1b

Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.